Karyopharm Therapeutics Inc. buy BiotechBee
Start price
20.07.23
/
60%
€1.38
Target price
20.07.24
€3.00
Performance (%)
-41.97%
End price
10.07.24
€0.80
Summary
This prediction ended on 10.07.24 with a price of €0.80. Massive losses of -41.97% were the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Karyopharm Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
According to BiotechBee what are the pros and cons of Karyopharm Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year